Straumann (OTCMKTS:SAUHY)‘s stock had its “outperform” rating reiterated by investment analysts at Credit Suisse Group in a research report issued on Wednesday, The Fly reports.
Several other research firms have also recently commented on SAUHY. Stifel Nicolaus cut shares of Straumann from a “buy” rating to a “hold” rating in a research note on Monday. JPMorgan Chase & Co. reissued an “underweight” rating on shares of Straumann in a research note on Thursday, October 29th. Morgan Stanley reissued an “underweight” rating on shares of Straumann in a research note on Wednesday, December 9th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Straumann in a research note on Tuesday, October 6th. Finally, Berenberg Bank reaffirmed a “hold” rating on shares of Straumann in a research note on Wednesday, October 14th. Three investment analysts have rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the stock. The stock presently has a consensus rating of “Hold”.
OTCMKTS SAUHY traded up $0.34 during trading hours on Wednesday, reaching $56.86. The company’s stock had a trading volume of 6,275 shares, compared to its average volume of 7,411. The business has a 50-day simple moving average of $58.45 and a 200 day simple moving average of $53.06. Straumann has a 52 week low of $27.34 and a 52 week high of $63.07.
Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implant systems, biomaterials, CADCAM prosthetics, digital equipment, software, clear aligner systems, and various materials for dental applications. The company offers dental implant systems for tissue and bone level; titanium, titanium alloy, ceramic, and mini dental implant systems; and guided and non-guided surgical instruments, as well as implant-borne prosthetics.
Recommended Story: Strangles
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.